These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29032509)

  • 1. Systemic trichosporonosis mimicking disseminated varicella zoster viral infection during blinatumomab therapy.
    Chan TSY; Kwong YL
    Ann Hematol; 2018 Feb; 97(2):371-373. PubMed ID: 29032509
    [No Abstract]   [Full Text] [Related]  

  • 2. Blinatumomab and pancreatitis: an analysis of FAERS, EudraVigilance, and a large urban U.S. patient population data.
    Vakharia P; Nardone B; Budris W; Hoshizaki K; Frankfurt O; West DP
    Leuk Lymphoma; 2018 Jul; 59(7):1759-1761. PubMed ID: 29115884
    [No Abstract]   [Full Text] [Related]  

  • 3. Inotuzumab ozogamicin, a nonchemotherapy option for relapsed acute lymphoblastic leukemia.
    Kantarjian HM
    Clin Adv Hematol Oncol; 2019 May; 17(5):268-270. PubMed ID: 31188803
    [No Abstract]   [Full Text] [Related]  

  • 4. Bispecific antibodies in acute lymphoblastic leukemia therapy.
    Chitadze G; Laqua A; Lettau M; Baldus CD; Brüggemann M
    Expert Rev Hematol; 2020 Nov; 13(11):1211-1233. PubMed ID: 33000968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption.
    Nguyen JK; Schlichte MJ; Schady D; Pourciau CY
    Pediatr Dermatol; 2018 Jan; 35(1):e86-e87. PubMed ID: 29266471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1/2 study of blinatumomab in relapsed paediatric ALL.
    Brower V
    Lancet Oncol; 2016 Dec; 17(12):e525. PubMed ID: 27839960
    [No Abstract]   [Full Text] [Related]  

  • 7. Blinatumomab significantly improves overall survival.
    Burki TK
    Lancet Oncol; 2017 Apr; 18(4):e203. PubMed ID: 28285842
    [No Abstract]   [Full Text] [Related]  

  • 8. Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab.
    Puzzolo MC; Radice G; Peragine N; de Propris MS; Mariglia P; Vignetti M; Vitale A; Bassan R; Annunziata M; Gaidano G; Rambaldi A; Chiaretti S; Guarini A; Foà R
    Blood; 2021 Dec; 138(22):2290-2293. PubMed ID: 34297829
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia.
    Ribera JM
    Expert Rev Hematol; 2017 Dec; 10(12):1057-1067. PubMed ID: 29082835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
    Gore L; Locatelli F; Zugmaier G; Handgretinger R; O'Brien MM; Bader P; Bhojwani D; Schlegel PG; Tuglus CA; von Stackelberg A
    Blood Cancer J; 2018 Aug; 8(9):80. PubMed ID: 30190453
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
    Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
    Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Targeted Immunotherapy as Induction or Salvage Therapy in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
    Ponvilawan B; Vittayawacharin P; Tunsing P; Owattanapanich W
    Technol Cancer Res Treat; 2021; 20():15330338211037434. PubMed ID: 34350787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A closer look at blinatumomab.
    Mattison RJ
    Clin Adv Hematol Oncol; 2018 Jun; 16(6):412-414. PubMed ID: 30067611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable remissions in
    Mouttet B; Vinti L; Ancliff P; Bodmer N; Brethon B; Cario G; Chen-Santel C; Elitzur S; Hazar V; Kunz J; Möricke A; Stein J; Vora A; Yaman Y; Schrappe M; Anak S; Baruche A; Locatelli F; von Stackelberg A; Stanulla M; Bourquin JP
    Haematologica; 2019 Jun; 104(6):e244-e247. PubMed ID: 30765470
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporating Immunotherapy Into the Treatment Strategies of B-Cell Adult Acute Lymphoblastic Leukemia: The Role of Blinatumomab and Inotuzumab Ozogamicin.
    Kantarjian H; Jabbour E
    Am Soc Clin Oncol Educ Book; 2018 May; 38():574-578. PubMed ID: 30231308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blinatumomab-Associated Neurological Adverse Events.
    Ahmed G; Khan R; Kamireddy C; Qadir H; Khan I; Gul Z
    Am J Ther; 2020; 27(5):e543-e547. PubMed ID: 32902938
    [No Abstract]   [Full Text] [Related]  

  • 17. Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B-cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia.
    Elitzur S; Arad-Cohen N; Barzilai-Birenboim S; Ben-Harush M; Bielorai B; Elhasid R; Feuerstein T; Gilad G; Gural A; Kharit M; Litichever N; Nirel R; Weinreb S; Wolach O; Toren A; Izraeli S; Jacoby E
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27898. PubMed ID: 31264788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
    Topp MS; Gökbuget N; Stein AS; Zugmaier G; O'Brien S; Bargou RC; Dombret H; Fielding AK; Heffner L; Larson RA; Neumann S; Foà R; Litzow M; Ribera JM; Rambaldi A; Schiller G; Brüggemann M; Horst HA; Holland C; Jia C; Maniar T; Huber B; Nagorsen D; Forman SJ; Kantarjian HM
    Lancet Oncol; 2015 Jan; 16(1):57-66. PubMed ID: 25524800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated trichosporonosis with atypical histologic findings in a patient with acute lymphocytic leukemia.
    Galligan ER; Fix L; Husain S; Zachariah P; Yamashiro DJ; Lauren CT
    J Cutan Pathol; 2019 Feb; 46(2):159-161. PubMed ID: 30468020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Trichosporonosis in a 2-Year-old With Acute Lymphoblastic Leukemia.
    Nguyen M; Naeem F; Razzaqi F; Vijayan V
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1254-e1255. PubMed ID: 34001782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.